This study verified the effects of baricitinib treatment on STAT phosphorylation in peripheral blood mononuclear cells (PBMCs) of RA patients and evaluated any correlation between STAT phosphorylation status and treatment response. Here, SOAT1 is linked to rheumatoid arthritis.